On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study

Is it Pre- or Postsynaptic? Imaging Striatal Dopamine Excess in Schizophrenia

(2018) Mark Slifstein et al.   BIOLOGICAL PSYCHIATRY

Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia

(2018) W. Gordon Frankle et al.   BIOLOGICAL PSYCHIATRY

Memory and cognition in schizophrenia

(2018) J. Y. Guo et al.   MOLECULAR PSYCHIATRY

Regional and source-based patterns of [ 11 C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D 2 and D 3 receptor availability in cocaine-use disorder

(2017) Patrick D. Worhunsky et al.   NEUROIMAGE

Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia

(2017) Huai-Hsuan Tseng et al.   SCHIZOPHRENIA BULLETIN

Making Sense of: Sensitization in Schizophrenia

(2016) Ana Weidenauer et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Kraepelin revisited: schizophrenia from degeneration to failed regeneration

(2015) P Falkai et al.   MOLECULAR PSYCHIATRY

Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine

(2015) Il Hwan Kim et al.   NATURE NEUROSCIENCE

In Vivo Amphetamine Action is Contingent on αCaMKII

(2014) Thomas Steinkellner et al.   NEUROPSYCHOPHARMACOLOGY

Dopaminergic basis of salience dysregulation in psychosis

(2014) Toby T. Winton-Brown et al.   TRENDS IN NEUROSCIENCES

Reliable set-up for in-loop 11C-carboxylations using Grignard reactions for the preparation of [carbonyl-11C]WAY-100635 and [11C]-(+)-PHNO

(2013) Christina Rami-Mark et al.   APPLIED RADIATION AND ISOTOPES

The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment

(2012) Oliver D. Howes et al.   ARCHIVES OF GENERAL PSYCHIATRY

Higher Binding of the Dopamine D3 Receptor-Preferring Ligand [11C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study

(2012) I. Boileau et al.   JOURNAL OF NEUROSCIENCE

Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies

(2012) Paolo Fusar-Poli et al.   SCHIZOPHRENIA BULLETIN

How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission

(2011) David Sulzer   NEURON

Within-subject comparison of the sensitivity of [11C]-(+)-PHNO and [11C]raclopride to amphetamine induced changes in endogenous dopamine in healthy human volunteers

(2010) Paul Shotbolt et al.   NEUROIMAGE

Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature

(2010) Christophe Destrieux et al.   NEUROIMAGE

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy

(2010) Andri C. Tziortzi et al.   NEUROIMAGE

Dissociating neural subsystems for grammar by contrasting word order and inflection

(2010) A. J. Newman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925

(2009) Ariel Graff-Guerrero et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis

(2009) P Fusar-Poli et al.   MOLECULAR PSYCHIATRY

The effects of lorazepam on extrastriatal dopamine D2/3-receptors—A double-blind randomized placebo-controlled PET study

(2009) Harry Vilkman et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway

(2009) O. D. Howes et al.   SCHIZOPHRENIA BULLETIN

In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice

(2009) Eugenii A. Rabiner et al.   SYNAPSE

Impairment of Working Memory Maintenance and Response in Schizophrenia: Functional Magnetic Resonance Imaging Evidence

(2008) Naomi R. Driesen et al.   BIOLOGICAL PSYCHIATRY